Cargando…

Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic

Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consu...

Descripción completa

Detalles Bibliográficos
Autores principales: González-López, María del Carmen, Díaz-Calvo, Virginia, Ruíz-González, Carlos, Nievas-Soriano, Bruno José, Rebollo-Lavado, Belén, Parrón-Carreño, Tesifón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030027/
https://www.ncbi.nlm.nih.gov/pubmed/35457647
http://dx.doi.org/10.3390/ijerph19084782
_version_ 1784692043860148224
author González-López, María del Carmen
Díaz-Calvo, Virginia
Ruíz-González, Carlos
Nievas-Soriano, Bruno José
Rebollo-Lavado, Belén
Parrón-Carreño, Tesifón
author_facet González-López, María del Carmen
Díaz-Calvo, Virginia
Ruíz-González, Carlos
Nievas-Soriano, Bruno José
Rebollo-Lavado, Belén
Parrón-Carreño, Tesifón
author_sort González-López, María del Carmen
collection PubMed
description Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consumption in vulnerable population groups. Methods: A cross-sectional observational study was performed in a primary health district of Spain. The data were obtained from the Andalusian Public Health System database, for the pre-COVID-19 period, from March 2019 to February 2020, and for the COVID-19 period, from March 2020 to February 2021. Univariant and bivariant analyses were performed. The effect size was measured using the Rosenthal test. Results: While the total number of medical prescriptions decreased by 2.5% in the COVID-19 period, the prescriptions of psychiatric drugs increased by 6.1%. The increase in the dose consumption per 1000 inhabitants (DHD) was highest for anxiolytics (7.2%), followed by hypnotic-sedatives (5.6%) and antidepressants (3.7%). The consumption of antidepressants, anxiolytics, and sedative-hypnotic drugs was higher in women, older people, and rural areas and lower in areas with social transformation needs, with these differences being statistically significant. Conclusions: The consumption of psychiatric drugs has increased over the COVID-19 pandemic, especially in women, older people, and rural areas. Thus, we should reflect on the adequate use of these drugs.
format Online
Article
Text
id pubmed-9030027
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90300272022-04-23 Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas-Soriano, Bruno José Rebollo-Lavado, Belén Parrón-Carreño, Tesifón Int J Environ Res Public Health Article Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consumption in vulnerable population groups. Methods: A cross-sectional observational study was performed in a primary health district of Spain. The data were obtained from the Andalusian Public Health System database, for the pre-COVID-19 period, from March 2019 to February 2020, and for the COVID-19 period, from March 2020 to February 2021. Univariant and bivariant analyses were performed. The effect size was measured using the Rosenthal test. Results: While the total number of medical prescriptions decreased by 2.5% in the COVID-19 period, the prescriptions of psychiatric drugs increased by 6.1%. The increase in the dose consumption per 1000 inhabitants (DHD) was highest for anxiolytics (7.2%), followed by hypnotic-sedatives (5.6%) and antidepressants (3.7%). The consumption of antidepressants, anxiolytics, and sedative-hypnotic drugs was higher in women, older people, and rural areas and lower in areas with social transformation needs, with these differences being statistically significant. Conclusions: The consumption of psychiatric drugs has increased over the COVID-19 pandemic, especially in women, older people, and rural areas. Thus, we should reflect on the adequate use of these drugs. MDPI 2022-04-14 /pmc/articles/PMC9030027/ /pubmed/35457647 http://dx.doi.org/10.3390/ijerph19084782 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
González-López, María del Carmen
Díaz-Calvo, Virginia
Ruíz-González, Carlos
Nievas-Soriano, Bruno José
Rebollo-Lavado, Belén
Parrón-Carreño, Tesifón
Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic
title Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic
title_full Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic
title_fullStr Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic
title_full_unstemmed Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic
title_short Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic
title_sort consumption of psychiatric drugs in primary care during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030027/
https://www.ncbi.nlm.nih.gov/pubmed/35457647
http://dx.doi.org/10.3390/ijerph19084782
work_keys_str_mv AT gonzalezlopezmariadelcarmen consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic
AT diazcalvovirginia consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic
AT ruizgonzalezcarlos consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic
AT nievassorianobrunojose consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic
AT rebollolavadobelen consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic
AT parroncarrenotesifon consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic